カテゴリー： 世界, 医療/バイオ, P&S Market Research

アレルギー診断のグローバル市場：製品別、アレルゲン別、検査タイプ別、エンドユーザー別

P&S Market Researchが出版した調査資料（PS24MAR048）・商品コード：PS24MAR048
・発行会社（調査会社）：P&S Market Research
・発行日：2023年11月
・ページ数：230
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Group UserUSD6,400 ⇒換算￥972,800見積依頼/購入/質問フォーム
Enterprise UserUSD8,400 ⇒換算￥1,276,800見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

アレルギー診断市場は、2023年には6,103.3百万米ドルに達し、2030年には複合年間成長率11.2％で12,814.2百万米ドルに達すると推定されます。
この産業の成長の背景には、環境汚染レベルの上昇、民間・公的機関によるアレルギー診断強化投資の増加、アレルギー疾患の発生があります。

さらに、喫煙、飲酒、不摂生な食生活を特徴とする不活発なライフスタイルが、体外血液検査の高い需要と相まって、業界の拡大をさらに後押しします。

2023年には、消耗品カテゴリーが45％のシェアで業界をリードしています。これは、消耗品がアレルギーの検出において重要な要素であるためと考えられます。

さらに、このカテゴリーは、アレルゲン・マイクロアレイ・ツールの登場を含む技術的強化により進歩し続けるでしょう。これらのツールは非常に感度が高く、患者に合わせたモニタリングやプロファイリングを提供します。

アレルゲンに基づく吸入カテゴリーは、2023年のアレルギー診断薬市場において35%のシェアを占め、最大の貢献者です。これは、環境汚染や花粉汚染の増加に加え、カビ、真菌、ホコリへの曝露が増加しているためです。

さらに、これらの薬剤の存在により、喘息やその他の呼吸器系アレルギーの発生が世界中で増加しています。

一方、この医薬品カテゴリーは今後数年間、高いペースで進歩する可能性が高いです。この背景には、高齢者の慢性疾患による薬剤消費の増加や、併用薬や併存疾患を含むその他の理由があります。

2023年には、検査タイプに基づくin-vivoカテゴリーが65%のシェアで業界を支配しています。これは、この検査が簡便に使用でき、入手可能性、感度、有効性が向上しているためです。

エンドユーザー別に見ると、2023年には診断検査室カテゴリーが30%のシェアで業界に最も貢献しています。これは、専門家による正確な診断を必要とする人が増えているためと考えられます。

2023年には北米が55%のシェアで業界をリードしています。これは、強力な医療制度、医療分野における迅速な技術開発、有利な償還規則が理由と考えられます。

さらに、アレルギーの発生が急増していることに加え、意識を高め、治療と診断を利用できるようにするための協会による刺激的な処置が存在することも大きな要因となっています。

APAC地域は、今後数年間で11.5％と最も高い成長率を示すでしょう。これは主に、侵襲性の低い診断技術への要求、医療インフラの急速な成長、医療ツーリズム活動の急増、満たされない臨床要件に起因します。

環境汚染レベルの上昇に伴い、アレルギー診断業界は今後数年間も進歩し続けるでしょう。

アレルギー診断ソリューション提供のトップ企業は以下の通りです：
bioMerieux S.A.
Danaher Corporation
Romer Labs Division Holding GmbH
HOB Biotech Group Corp Ltd
HYCOR Biomedical LLC
NEOGEN Corporation
Eurofins Scientific S.E.
Siemens Healthcare GmbH
Stallergenes Greer International AG
Thermo Fisher Scientific

第1章．調査範囲
第2章．調査方法
第3章．エグゼクティブサマリー
第4章．市場指標
第5章．産業動向
第6章．世界市場
第7章．北米市場
第8章．ヨーロッパ市場
第9章．アジア太平洋市場
第10章．中南米市場
第11章．中東/アフリカ市場
第12章．アメリカ市場
第13章．カナダ市場
第14章．ドイツ市場
第15章．フランス市場
第16章．イギリス市場
第17章．イタリア市場
第18章．スペイン市場
第19章．日本市場
第20章．中国市場
第21章．インド市場
第22章．オーストラリア市場
第23章．韓国市場
第24章．ブラジル市場
第25章．メキシコ市場
第26章．サウジアラビア市場
第27章．南アフリカ市場
第28章．中東市場
第29章．競争状況
第30章．企業情報
第31章．付録

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Chapter 1. Research Scope

1.1. Research Objectives

1.2. Market Definition

1.3. Analysis Period

1.4. Market Size Breakdown by Segments

1.4.1. Market size breakdown, by offering

1.4.2. Market size breakdown, by allergen

1.4.3. Market size breakdown, by test type

1.4.4. Market size breakdown, by end user

1.4.5. Market size breakdown, by region

1.4.6. Market size breakdown, by country

1.5. Market Data Reporting Unit

1.5.1. Volume

1.5.2. Value

1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.1.1. Paid

2.1.2. Unpaid

2.1.3. P&S Intelligence database

2.2. Primary Research

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Currency Conversion Rates

2.6. Assumptions for the Study

2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

5.1. Market Dynamics

5.1.1. Trends

5.1.2. Drivers

5.1.3. Restraints/challenges

5.1.4. Impact analysis of drivers/restraints

5.2. Impact of COVID-19

5.3. Porter’s Five Forces Analysis

5.3.1. Bargaining power of buyers

5.3.2. Bargaining power of suppliers

5.3.3. Threat of new entrants

5.3.4. Intensity of rivalry

5.3.5. Threat of substitutes

Chapter 6. Global Market

6.1. Overview

6.2. Market Volume, by Offering (2017–2030)

6.2.1. Instruments market volume, by type (2017–2030)

6.3. Market Revenue, by Offering (2017–2030)

6.3.1. Instruments market revenue, by type (2017–2030)

6.4. Market Volume, by Allergen (2017–2030)

6.5. Market Revenue, by Allergen (2017–2030)

6.6. Market Volume, by Test Type (2017–2030)

6.7. Market Revenue, by Test Type (2017–2030)

6.8. Market Volume, by End User (2017–2030)

6.9. Market Revenue, by End User (2017–2030)

6.10. Market Volume, by Region (2017–2030)

6.11. Market Revenue, by Region (2017–2030)

Chapter 7. North America Market

7.1. Overview

7.2. Market Volume, by Offering (2017–2030)

7.2.1. Instruments market volume, by type (2017–2030)

7.3. Market Revenue, by Offering (2017–2030)

7.3.1. Instruments market revenue, by type (2017–2030)

7.4. Market Volume, by Allergen (2017–2030)

7.5. Market Revenue, by Allergen (2017–2030)

7.6. Market Volume, by Test Type (2017–2030)

7.7. Market Revenue, by Test Type (2017–2030)

7.8. Market Volume, by End User (2017–2030)

7.9. Market Revenue, by End User (2017–2030)

7.10. Market Volume, by Country (2017–2030)

7.11. Market Revenue, by Country (2017–2030)

Chapter 8. Europe Market

8.1. Overview

8.2. Market Volume, by Offering (2017–2030)

8.2.1. Instruments market volume, by type (2017–2030)

8.3. Market Revenue, by Offering (2017–2030)

8.3.1. Instruments market revenue, by type (2017–2030)

8.4. Market Volume, by Allergen (2017–2030)

8.5. Market Revenue, by Allergen (2017–2030)

8.6. Market Volume, by Test Type (2017–2030)

8.7. Market Revenue, by Test Type (2017–2030)

8.8. Market Volume, by End User (2017–2030)

8.9. Market Revenue, by End User (2017–2030)

8.10. Market Volume, by Country (2017–2030)

8.11. Market Revenue, by Country (2017–2030)

Chapter 9. APAC Market

9.1. Overview

9.2. Market Volume, by Offering (2017–2030)

9.2.1. Instruments market volume, by type (2017–2030)

9.3. Market Revenue, by Offering (2017–2030)

9.3.1. Instruments market revenue, by type (2017–2030)

9.4. Market Volume, by Allergen (2017–2030)

9.5. Market Revenue, by Allergen (2017–2030)

9.6. Market Volume, by Test Type (2017–2030)

9.7. Market Revenue, by Test Type (2017–2030)

9.8. Market Volume, by End User (2017–2030)

9.9. Market Revenue, by End User (2017–2030)

9.10. Market Volume, by Country (2017–2030)

9.11. Market Revenue, by Country (2017–2030)

Chapter 10. LATAM Market

10.1. Overview

10.2. Market Volume, by Offering (2017–2030)

10.2.1. Instruments market volume, by type (2017–2030)

10.3. Market Revenue, by Offering (2017–2030)

10.3.1. Instruments market revenue, by type (2017–2030)

10.4. Market Volume, by Allergen (2017–2030)

10.5. Market Revenue, by Allergen (2017–2030)

10.6. Market Volume, by Test Type (2017–2030)

10.7. Market Revenue, by Test Type (2017–2030)

10.8. Market Volume, by End User (2017–2030)

10.9. Market Revenue, by End User (2017–2030)

10.10. Market Volume, by Country (2017–2030)

10.11. Market Revenue, by Country (2017–2030)

Chapter 11. MEA Market

11.1. Overview

11.2. Market Volume, by Offering (2017–2030)

11.2.1. Instruments market volume, by type (2017–2030)

11.3. Market Revenue, by Offering (2017–2030)

11.3.1. Instruments market revenue, by type (2017–2030)

11.4. Market Volume, by Allergen (2017–2030)

11.5. Market Revenue, by Allergen (2017–2030)

11.6. Market Volume, by Test Type (2017–2030)

11.7. Market Revenue, by Test Type (2017–2030)

11.8. Market Volume, by End User (2017–2030)

11.9. Market Revenue, by End User (2017–2030)

11.10. Market Volume, by Country (2017–2030)

11.11. Market Revenue, by Country (2017–2030)

Chapter 12. U.S. Market

12.1. Overview

12.2. Market Volume, by Offering (2017–2030)

12.2.1. Instruments market volume, by type (2017–2030)

12.3. Market Revenue, by Offering (2017–2030)

12.3.1. Instruments market revenue, by type (2017–2030)

12.4. Market Volume, by Allergen (2017–2030)

12.5. Market Revenue, by Allergen (2017–2030)

12.6. Market Volume, by Test Type (2017–2030)

12.7. Market Revenue, by Test Type (2017–2030)

12.8. Market Volume, by End User (2017–2030)

12.9. Market Revenue, by End User (2017–2030)

Chapter 13. Canada Market

13.1. Overview

13.2. Market Volume, by Offering (2017–2030)

13.2.1. Instruments market volume, by type (2017–2030)

13.3. Market Revenue, by Offering (2017–2030)

13.3.1. Instruments market revenue, by type (2017–2030)

13.4. Market Volume, by Allergen (2017–2030)

13.5. Market Revenue, by Allergen (2017–2030)

13.6. Market Volume, by Test Type (2017–2030)

13.7. Market Revenue, by Test Type (2017–2030)

13.8. Market Volume, by End User (2017–2030)

13.9. Market Revenue, by End User (2017–2030)

Chapter 14. Germany Market

14.1. Overview

14.2. Market Volume, by Offering (2017–2030)

14.2.1. Instruments market volume, by type (2017–2030)

14.3. Market Revenue, by Offering (2017–2030)

14.3.1. Instruments market revenue, by type (2017–2030)

14.4. Market Volume, by Allergen (2017–2030)

14.5. Market Revenue, by Allergen (2017–2030)

14.6. Market Volume, by Test Type (2017–2030)

14.7. Market Revenue, by Test Type (2017–2030)

14.8. Market Volume, by End User (2017–2030)

14.9. Market Revenue, by End User (2017–2030)

Chapter 15. France Market

15.1. Overview

15.2. Market Volume, by Offering (2017–2030)

15.2.1. Instruments market volume, by type (2017–2030)

15.3. Market Revenue, by Offering (2017–2030)

15.3.1. Instruments market revenue, by type (2017–2030)

15.4. Market Volume, by Allergen (2017–2030)

15.5. Market Revenue, by Allergen (2017–2030)

15.6. Market Volume, by Test Type (2017–2030)

15.7. Market Revenue, by Test Type (2017–2030)

15.8. Market Volume, by End User (2017–2030)

15.9. Market Revenue, by End User (2017–2030)

Chapter 16. U.K. Market

16.1. Overview

16.2. Market Volume, by Offering (2017–2030)

16.2.1. Instruments market volume, by type (2017–2030)

16.3. Market Revenue, by Offering (2017–2030)

16.3.1. Instruments market revenue, by type (2017–2030)

16.4. Market Volume, by Allergen (2017–2030)

16.5. Market Revenue, by Allergen (2017–2030)

16.6. Market Volume, by Test Type (2017–2030)

16.7. Market Revenue, by Test Type (2017–2030)

16.8. Market Volume, by End User (2017–2030)

16.9. Market Revenue, by End User (2017–2030)

Chapter 17. Italy Market

17.1. Overview

17.2. Market Volume, by Offering (2017–2030)

17.2.1. Instruments market volume, by type (2017–2030)

17.3. Market Revenue, by Offering (2017–2030)

17.3.1. Instruments market revenue, by type (2017–2030)

17.4. Market Volume, by Allergen (2017–2030)

17.5. Market Revenue, by Allergen (2017–2030)

17.6. Market Volume, by Test Type (2017–2030)

17.7. Market Revenue, by Test Type (2017–2030)

17.8. Market Volume, by End User (2017–2030)

17.9. Market Revenue, by End User (2017–2030)

Chapter 18. Spain Market

18.1. Overview

18.2. Market Volume, by Offering (2017–2030)

18.2.1. Instruments market volume, by type (2017–2030)

18.3. Market Revenue, by Offering (2017–2030)

18.3.1. Instruments market revenue, by type (2017–2030)

18.4. Market Volume, by Allergen (2017–2030)

18.5. Market Revenue, by Allergen (2017–2030)

18.6. Market Volume, by Test Type (2017–2030)

18.7. Market Revenue, by Test Type (2017–2030)

18.8. Market Volume, by End User (2017–2030)

18.9. Market Revenue, by End User (2017–2030)

Chapter 19. Japan Market

19.1. Overview

19.2. Market Volume, by Offering (2017–2030)

19.2.1. Instruments market volume, by type (2017–2030)

19.3. Market Revenue, by Offering (2017–2030)

19.3.1. Instruments market revenue, by type (2017–2030)

19.4. Market Volume, by Allergen (2017–2030)

19.5. Market Revenue, by Allergen (2017–2030)

19.6. Market Volume, by Test Type (2017–2030)

19.7. Market Revenue, by Test Type (2017–2030)

19.8. Market Volume, by End User (2017–2030)

19.9. Market Revenue, by End User (2017–2030)

Chapter 20. China Market

20.1. Overview

20.2. Market Volume, by Offering (2017–2030)

20.2.1. Instruments market volume, by type (2017–2030)

20.3. Market Revenue, by Offering (2017–2030)

20.3.1. Instruments market revenue, by type (2017–2030)

20.4. Market Volume, by Allergen (2017–2030)

20.5. Market Revenue, by Allergen (2017–2030)

20.6. Market Volume, by Test Type (2017–2030)

20.7. Market Revenue, by Test Type (2017–2030)

20.8. Market Volume, by End User (2017–2030)

20.9. Market Revenue, by End User (2017–2030)

Chapter 21. India Market

21.1. Overview

21.2. Market Volume, by Offering (2017–2030)

21.2.1. Instruments market volume, by type (2017–2030)

21.3. Market Revenue, by Offering (2017–2030)

21.3.1. Instruments market revenue, by type (2017–2030)

21.4. Market Volume, by Allergen (2017–2030)

21.5. Market Revenue, by Allergen (2017–2030)

21.6. Market Volume, by Test Type (2017–2030)

21.7. Market Revenue, by Test Type (2017–2030)

21.8. Market Volume, by End User (2017–2030)

21.9. Market Revenue, by End User (2017–2030)

Chapter 22. Australia Market

22.1. Overview

22.2. Market Volume, by Offering (2017–2030)

22.2.1. Instruments market volume, by type (2017–2030)

22.3. Market Revenue, by Offering (2017–2030)

22.3.1. Instruments market revenue, by type (2017–2030)

22.4. Market Volume, by Allergen (2017–2030)

22.5. Market Revenue, by Allergen (2017–2030)

22.6. Market Volume, by Test Type (2017–2030)

22.7. Market Revenue, by Test Type (2017–2030)

22.8. Market Volume, by End User (2017–2030)

22.9. Market Revenue, by End User (2017–2030)

Chapter 23. South Korea Market

23.1. Overview

23.2. Market Volume, by Offering (2017–2030)

23.2.1. Instruments market volume, by type (2017–2030)

23.3. Market Revenue, by Offering (2017–2030)

23.3.1. Instruments market revenue, by type (2017–2030)

23.4. Market Volume, by Allergen (2017–2030)

23.5. Market Revenue, by Allergen (2017–2030)

23.6. Market Volume, by Test Type (2017–2030)

23.7. Market Revenue, by Test Type (2017–2030)

23.8. Market Volume, by End User (2017–2030)

23.9. Market Revenue, by End User (2017–2030)

Chapter 24. Brazil Market

24.1. Overview

24.2. Market Volume, by Offering (2017–2030)

24.2.1. Instruments market volume, by type (2017–2030)

24.3. Market Revenue, by Offering (2017–2030)

24.3.1. Instruments market revenue, by type (2017–2030)

24.4. Market Volume, by Allergen (2017–2030)

24.5. Market Revenue, by Allergen (2017–2030)

24.6. Market Volume, by Test Type (2017–2030)

24.7. Market Revenue, by Test Type (2017–2030)

24.8. Market Volume, by End User (2017–2030)

24.9. Market Revenue, by End User (2017–2030)

Chapter 25. Mexico Market

25.1. Overview

25.2. Market Volume, by Offering (2017–2030)

25.2.1. Instruments market volume, by type (2017–2030)

25.3. Market Revenue, by Offering (2017–2030)

25.3.1. Instruments market revenue, by type (2017–2030)

25.4. Market Volume, by Allergen (2017–2030)

25.5. Market Revenue, by Allergen (2017–2030)

25.6. Market Volume, by Test Type (2017–2030)

25.7. Market Revenue, by Test Type (2017–2030)

25.8. Market Volume, by End User (2017–2030)

25.9. Market Revenue, by End User (2017–2030)

Chapter 26. Saudi Arabia Market

26.1. Overview

26.2. Market Volume, by Offering (2017–2030)

26.2.1. Instruments market volume, by type (2017–2030)

26.3. Market Revenue, by Offering (2017–2030)

26.3.1. Instruments market revenue, by type (2017–2030)

26.4. Market Volume, by Allergen (2017–2030)

26.5. Market Revenue, by Allergen (2017–2030)

26.6. Market Volume, by Test Type (2017–2030)

26.7. Market Revenue, by Test Type (2017–2030)

26.8. Market Volume, by End User (2017–2030)

26.9. Market Revenue, by End User (2017–2030)

Chapter 27. South Africa Market

27.1. Overview

27.2. Market Volume, by Offering (2017–2030)

27.2.1. Instruments market volume, by type (2017–2030)

27.3. Market Revenue, by Offering (2017–2030)

27.3.1. Instruments market revenue, by type (2017–2030)

27.4. Market Volume, by Allergen (2017–2030)

27.5. Market Revenue, by Allergen (2017–2030)

27.6. Market Volume, by Test Type (2017–2030)

27.7. Market Revenue, by Test Type (2017–2030)

27.8. Market Volume, by End User (2017–2030)

27.9. Market Revenue, by End User (2017–2030)

Chapter 28. U.A.E. Market

28.1. Overview

28.2. Market Volume, by Offering (2017–2030)

28.2.1. Instruments market volume, by type (2017–2030)

28.3. Market Revenue, by Offering (2017–2030)

28.3.1. Instruments market revenue, by type (2017–2030)

28.4. Market Volume, by Allergen (2017–2030)

28.5. Market Revenue, by Allergen (2017–2030)

28.6. Market Volume, by Test Type (2017–2030)

28.7. Market Revenue, by Test Type (2017–2030)

28.8. Market Volume, by End User (2017–2030)

28.9. Market Revenue, by End User (2017–2030)

Chapter 29. Competitive Landscape

29.1. List of Market Players and their Offerings

29.2. Competitive Benchmarking of Key Players

29.3. Product Benchmarking of Key Players

29.4. Recent Strategic Developments

Chapter 30. Company Profiles

30.1. bioMerieux S.A.

30.1.1. Business overview

30.1.2. Product and service offerings

30.1.3. Key financial summary

30.2. Danaher Corporation

30.2.1. Business overview

30.2.2. Product and service offerings

30.2.3. Key financial summary

30.3. Romer Labs Division Holding GmbH

30.3.1. Business overview

30.3.2. Product and service offerings

30.3.3. Key financial summary

30.4. HOB Biotech Group Corp Ltd.

30.4.1. Business overview

30.4.2. Product and service offerings

30.4.3. Key financial summary

30.5. HYCOR Biomedical LLC

30.5.1. Business overview

30.5.2. Product and service offerings

30.5.3. Key financial summary

30.6. NEOGEN Corporation

30.6.1. Business overview

30.6.2. Product and service offerings

30.6.3. Key financial summary

30.7. Eurofins Scientific

30.7.1. Business overview

30.7.2. Product and service offerings

30.7.3. Key financial summary

30.8. Siemens Healthcare GmbH

30.8.1. Business overview

30.8.2. Product and service offerings

30.8.3. Key financial summary

30.9. Stallergenes Greer International AG

30.9.1. Business overview

30.9.2. Product and service offerings

30.9.3. Key financial summary

30.10. Thermo Fisher Scientific

30.10.1. Business overview

30.10.2. Product and service offerings

30.10.3. Key financial summary

Chapter 31. Appendix

31.1. Abbreviations

31.2. Sources and References

31.3. Related Reports



★調査レポート[アレルギー診断のグローバル市場：製品別、アレルゲン別、検査タイプ別、エンドユーザー別] (コード：PS24MAR048)販売に関する免責事項を必ずご確認ください。
★調査レポート[アレルギー診断のグローバル市場：製品別、アレルゲン別、検査タイプ別、エンドユーザー別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のアレルギー診断市場2020年-2030年：検査種類別（インビボ、インビトロ）、製品＆サービス別、アレルゲン別、エンドユーザー別
  • 世界のアレルギー診断市場2022年-2031年：検査種類別（インビボ、インビトロ）、製品/サービス別（消耗品、機器、サービス）、アレルゲン別（吸入アレルゲン、食物アレルゲン、薬物アレルゲン、その他）、エンドユーザー別（診断検査室、病院検査室、学術研究機関、その他）、地域別（北米、欧州、アジア太平洋、中南米・中東・アフリカ）
  • 世界の水質測定器市場2023年-2032年：製品タイプ別（携帯型、据置型）、検査タイプ別（濁度、pH、溶存酸素、導電率、TOC、その他）、エンドユーザー別（水処理プラント、研究所、工業、養殖、その他）
  • 世界の前立腺がん診断市場2024-2030：検査タイプ別（予備検査、確認検査）、種類別（腺がん、間質細胞がん、その他）、エンドユーザー別、地域別
  • 世界のがん診断市場2024-2030：製品別（消耗品、機器）、種類別（体外診断用医薬品、LDT）、用途別（乳がん、肺がん）、エンドユーザー別、検査タイプ別
  • 世界のインフルエンザ診断市場2024-2030：検査タイプ別（RIDT、RT-PCR、細胞培養）、エンドユーザー別（病院、研究所、POCT）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆